{"id":"https://openalex.org/W4399345686","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e24009","title":"Cardiovascular events in patients receiving immuno-oncology agents, in phase I clinical trials: CAVIO study.","display_name":"Cardiovascular events in patients receiving immuno-oncology agents, in phase I clinical trials: CAVIO study.","alternate_titles":[],"publication_year":2024,"publication_date":"2024-06-01","ids":{"openalex":"https://openalex.org/W4399345686","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e24009"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2024.42.16_suppl.e24009","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e24009","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.e24009","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4399345686"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009683915","display_name":"Paola Zagami","orcid":"https://orcid.org/0000-0002-2687-6436","observed_orcids":["https://orcid.org/0000-0002-2687-6436"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Paola Zagami","raw_affiliation_strings":["Division of Early Drug Development, European Institute of Oncology IRCCS, University of Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Early Drug Development, European Institute of Oncology IRCCS, University of Milan, Milan, Italy","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017374197","display_name":"Eleonora Nicol\u00f2","orcid":"https://orcid.org/0000-0001-5042-6550","observed_orcids":["https://orcid.org/0000-0001-5042-6550"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eleonora Nicol\u00f2","raw_affiliation_strings":["Weill Cornell Medicine, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medicine, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035150606","display_name":"Dario Trapani","orcid":"https://orcid.org/0000-0003-1672-9560","observed_orcids":["https://orcid.org/0000-0003-1672-9560"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Dario Trapani","raw_affiliation_strings":["Division of Early Drug Development, European Institute of Oncology IRCCS, University of Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Early Drug Development, European Institute of Oncology IRCCS, University of Milan, Milan, Italy","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065064948","display_name":"Luca Boscolo Bielo","orcid":"https://orcid.org/0000-0003-1026-3923","observed_orcids":["https://orcid.org/0000-0003-1026-3923"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Luca Boscolo Bielo","raw_affiliation_strings":["Division of Early Drug Development, European Institute of Oncology IRCCS, University of Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Early Drug Development, European Institute of Oncology IRCCS, University of Milan, Milan, Italy","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082304162","display_name":"Carmine Valenza","orcid":"https://orcid.org/0000-0003-1150-0345","observed_orcids":["https://orcid.org/0000-0003-1150-0345"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Carmine Valenza","raw_affiliation_strings":["Division of Early Drug Development, European Institute of Oncology IRCCS, University of Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Early Drug Development, European Institute of Oncology IRCCS, University of Milan, Milan, Italy","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043895586","display_name":"Ambra Carnevale Schianca","orcid":"https://orcid.org/0009-0007-9864-8284","observed_orcids":["https://orcid.org/0009-0007-9864-8284"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ambra Carnevale Schianca","raw_affiliation_strings":["Division of Early Drug Development, European Institute of Oncology IRCCS, University of Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Early Drug Development, European Institute of Oncology IRCCS, University of Milan, Milan, Italy","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066042637","display_name":"Gloria Pellizzari","orcid":"https://orcid.org/0009-0002-5733-2316","observed_orcids":["https://orcid.org/0009-0002-5733-2316"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gloria Pellizzari","raw_affiliation_strings":["Division of Early Drug Development, European Institute of Oncology IRCCS, University of Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Early Drug Development, European Institute of Oncology IRCCS, University of Milan, Milan, Italy","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035816076","display_name":"Grazia Castellano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Grazia Castellano","raw_affiliation_strings":["Division of Early Drug Development, European Institute of Oncology IRCCS, University of Milan, Milan, NA, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Early Drug Development, European Institute of Oncology IRCCS, University of Milan, Milan, NA, Italy","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015077519","display_name":"Sara Gandini","orcid":"https://orcid.org/0000-0002-1348-4548","observed_orcids":["https://orcid.org/0000-0002-1348-4548"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sara Gandini","raw_affiliation_strings":["IEO, European Institute of Oncology IRCCS, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IEO, European Institute of Oncology IRCCS, Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008609177","display_name":"Silvano Vignati","orcid":"https://orcid.org/0009-0006-9857-7060","observed_orcids":["https://orcid.org/0009-0006-9857-7060"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Silvano Vignati","raw_affiliation_strings":["IEO, European Institute of Oncology IRCCS, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IEO, European Institute of Oncology IRCCS, Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008449590","display_name":"Maria Angela Massaro","orcid":"https://orcid.org/0000-0002-8007-0839","observed_orcids":["https://orcid.org/0000-0002-8007-0839"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Angela Massaro","raw_affiliation_strings":["Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026700178","display_name":"C. Busacca","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Chiara Busacca","raw_affiliation_strings":["Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089982076","display_name":"Antonio Marra","orcid":"https://orcid.org/0000-0002-7310-7824","observed_orcids":["https://orcid.org/0000-0002-7310-7824"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Antonio Marra","raw_affiliation_strings":["Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024307883","display_name":"Beatrice Taurelli Salimbeni","orcid":"https://orcid.org/0000-0002-7345-4148","observed_orcids":["https://orcid.org/0000-0002-7345-4148"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Beatrice Taurelli Salimbeni","raw_affiliation_strings":["Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006175430","display_name":"Carmen Belli","orcid":"https://orcid.org/0000-0001-7067-7496","observed_orcids":["https://orcid.org/0000-0001-7067-7496"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Carmen Belli","raw_affiliation_strings":["Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016762975","display_name":"Ida Minchella","orcid":"https://orcid.org/0000-0002-2976-2346","observed_orcids":["https://orcid.org/0000-0002-2976-2346"]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ida Minchella","raw_affiliation_strings":["Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103565222","display_name":"Marzia Locatelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marzia Adelia Locatelli","raw_affiliation_strings":["Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103397296","display_name":"Angela Esp\u00f3sito","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Angela Esposito","raw_affiliation_strings":["Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Early Drug Development, European Institute of Oncology IRCCS, Milan, Milan, Italy","institution_ids":["https://openalex.org/I6141010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000459628","display_name":"Carmen Criscitiello","orcid":"https://orcid.org/0000-0001-9064-0113","observed_orcids":["https://orcid.org/0000-0001-9064-0113"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Carmen Criscitiello","raw_affiliation_strings":["Division of Early Drug Development, European Institute of Oncology IRCCS, University of Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Early Drug Development, European Institute of Oncology IRCCS, University of Milan, Milan, Italy","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I6141010"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003897511","display_name":"Giuseppe Curigliano","orcid":"https://orcid.org/0000-0003-1781-2518","observed_orcids":["https://orcid.org/0000-0003-1781-2518"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I6141010","display_name":"European Institute of Oncology","ror":"https://ror.org/02vr0ne26","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I6141010"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppe Curigliano","raw_affiliation_strings":["European Institute of Oncology, IRCCS, University of Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"European Institute of Oncology, IRCCS, University of Milan, Milan, Italy","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I6141010"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"16_suppl","first_page":"e24009","last_page":"e24009"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.8759999871253967,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.8759999871253967,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.11819999665021896,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11638","display_name":"Cardiac tumors and thrombi","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cardiovascular-events","display_name":"cardiovascular events","score":0.7350000143051147},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7570000290870667},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7979999780654907},{"id":"https://openalex.org/keywords/thrombosis","display_name":"thrombosis","score":0.9890000224113464},{"id":"https://openalex.org/keywords/myocarditis","display_name":"myocarditis","score":0.949999988079071},{"id":"https://openalex.org/keywords/anticoagulant-use","display_name":"anticoagulant use","score":0.8999999761581421},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7099999785423279},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8029999732971191},{"id":"https://openalex.org/keywords/performance-status","display_name":"performance status","score":0.5239999890327454},{"id":"https://openalex.org/keywords/cardiovascular-risk-factors","display_name":"cardiovascular risk factors","score":0.7919999957084656},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.5989999771118164},{"id":"https://openalex.org/keywords/cancer-immunotherapy-safety","display_name":"cancer immunotherapy safety","score":0.5389999747276306},{"id":"https://openalex.org/keywords/ecog-performance-status","display_name":"ECOG performance status","score":0.5979999899864197},{"id":"https://openalex.org/keywords/duration-of-anticoagulation","display_name":"anticoagulation duration","score":0.45500001311302185}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9103643298149109},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5642544031143188},{"id":"https://openalex.org/C2776598537","wikidata":"https://www.wikidata.org/wiki/Q1812651","display_name":"Clinical Oncology","level":3,"score":0.5337544083595276},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.513433575630188},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.49175694584846497},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3727344274520874},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.32743537425994873}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2024.42.16_suppl.e24009","doi":"https://doi.org/10.1200/jco.2024.42.16_suppl.e24009","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1200/jco.2024.42.16_suppl.e24009","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4200217584","https://openalex.org/W4281876121","https://openalex.org/W3200806721","https://openalex.org/W6980433757","https://openalex.org/W3170436333","https://openalex.org/W3198882735","https://openalex.org/W7162552743","https://openalex.org/W4214898225","https://openalex.org/W4311066672","https://openalex.org/W4402561045"],"abstract_inverted_index":{"e24009":[0],"Background:":[1],"Among":[2],"immunoncology":[3],"agents":[4],"(IO),":[5],"immune":[6],"checkpoint":[7],"inhibitors":[8],"are":[9,22,354],"the":[10,36,158,191,235,242,275,280,299,334,349,357],"most":[11,137,169,350],"used,":[12],"demonstrating":[13],"survival":[14,114,224],"benefit":[15],"across":[16],"multiple":[17],"cancer":[18],"types.":[19],"Adverse":[20],"events":[21,40],"often":[23],"reported":[24],"with":[25,70,208,214,307,339],"IO;":[26],"cardiotoxicity":[27],"is":[28],"rare,":[29,346],"but":[30],"potentially":[31],"fatal.":[32],"CAVIO":[33],"study":[34],"evaluated":[35],"occurrence":[37,202,328],"of":[38,60,80,140,147,153,160,203,216,244,283,289,301,329,336,359],"cardiovascular":[39,210],"(CVE)":[41],"in":[42,46,68,74,293,341],"patients":[43,61,128,149,196,337,364],"receiving":[44],"IO":[45,71,340,362],"phase":[47],"I":[48],"clinical":[49,56],"trials":[50],"(ph1CT).":[51],"Methods:":[52],"We":[53],"retrospectively":[54],"reviewed":[55],"and":[57,78,102,111,119,165,178,226,230,249,252,260,291,298,363],"cardiological":[58],"data":[59,353],"consecutively":[62],"enrolled,":[63],"from":[64],"Jan2016":[65],"to":[66,88,97],"Dec2021,":[67],"ph1CT":[69,245],"alone":[72],"or":[73,86,199],"combination.":[75],"Any":[76],"type":[77],"grade":[79,155],"CVE":[81,152,198,204,236,330,344],"occurred":[82],"on":[83,356],"treatment,":[84,159],"related":[85],"not":[87,206,258,332],"IO,":[89],"was":[90,133,143,205,263,272],"evaluated.":[91],"Fisher\u2019s":[92],"exact":[93],"tests":[94],"were":[95,106,124,129,172,228,345],"used":[96,107],"compare":[98],"variables.":[99],"Cox":[100],"regression":[101],"Kaplan":[103],"Meier":[104],"methods":[105],"for":[108,264,279,319],"multivariable":[109],"analyses":[110],"estimating":[112],"overall":[113],"(OS).":[115],"Hazard":[116],"ratio":[117],"(HR)":[118],"95%":[120,313],"confident":[121],"interval":[122],"(CI)":[123],"calculated.":[125],"Results:":[126],"211":[127,148],"included;":[130],"median":[131,221],"age":[132],"57":[134],"years.":[135],"The":[136,168,201,220,270,327],"frequent":[138,170],"site":[139,282],"primary":[141,281],"tumor":[142],"breast":[144],"(25%).":[145],"43":[146],"experienced":[150],"\u22651":[151],"any":[154],"(G)":[156],"during":[157],"which":[161,294],"<":[162,317],"1%":[163],"G3":[164],"none":[166],"\u00b3G4.":[167],"ones":[171],"hypertension":[173,347],"(n":[174,180],"=":[175,181],"20,":[176],"9%)":[177],"thrombosis":[179],"15,":[182],"7%),":[183],"only":[184],"one":[185],"myocarditis":[186],"(2%).":[187],"Table":[188],"1":[189,267,297],"shows":[190],"significant":[192,305],"differences":[193],"observed":[194],"between":[195],"experiencing":[197],"not.":[200],"associated":[207,306],"pre-existing":[209],"risk":[211],"factors":[212],"nor":[213],"number":[215],"prior":[217],"therapy":[218],"lines.":[219],"progression":[222],"free":[223],"(mPFS)":[225],"mOS":[227],"2":[229],"9":[231],"months":[232],"respectively,":[233],"regardless":[234],"occurrence.":[237],"Patients":[238],"using":[239],"anticoagulant":[240,302,320,360],"at":[241,274],"end":[243],"showed":[246],"worse":[247],"PFS":[248],"OS":[250,309],"(1.8":[251],"5.4m)":[253],"than":[254],"those":[255],"who":[256],"did":[257,331],"(2.5":[259],"11.1m),":[261],"similarly":[262],"PS":[265,285,295],"ECOG":[266,296],"vs":[268],"0.":[269],"result":[271],"consistent":[273],"multivariate":[276],"model":[277],"adjusted":[278],"tumor,":[284],"ECOG,":[286],"previous":[287],"lines":[288],"treatment":[290],"age,":[292],"use":[300],"remained":[303],"statistically":[304],"negative":[308],"(for":[310],"PSECOG:":[311],"HR:1.84,":[312],"CI":[314],"1.31-2.57,":[315],"p":[316],"0.001;":[318],"use:":[321],"HR:":[322],"1.72,":[323],"95%CI:1.20-2.47,":[324],"p:0.003).":[325],"Conclusions:":[326],"change":[333],"outcomes":[335],"treated":[338],"ph1RC.":[342],"Severe":[343],"being":[348],"frequent.":[351],"Further":[352],"needed":[355],"correlation":[358],"use,":[361],"prognosis.":[365],"[Table:":[366],"see":[367],"text]":[368]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4399345686","counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2024-06-05T00:00:00"}
